2011 ASH Advocacy Leadership Institute

2011 ASH Advocacy Leadership Institute Summary and Agenda

As part of the ASH Recruitment & Retention Initiative and in order to provide additional opportunities for ASH members to learn more about advocacy and become engaged in the Society, the ASH Government Relations, Practice, and Scientific Affairs department held a two-day workshop – the ASH Advocacy Leadership Institute – on October 12 and 13, 2011. The selection of participants was based on a nomination process; over 40 nominations were received. The final 21 participants were a diverse mix of basic and clinical researchers and practitioners, junior, mid-career and senior faculty, malignant and non-malignant hematologists, as well as gender and geographic location.

The first day of the Institute focused on learning about the legislative process, health policy, and advocacy strategies. Faculty of the Advocacy Leadership Institute included ASH Government Relations staff and consultants as well as guest speakers from the Administration, Congress, and other advocacy organizations, including former Congressman Michael N. Castle and the Director of the National Institute of Diabetes and Digestive and Kidney Diseases, Dr. Griffin Rodgers. The second day included visits to nearly 50 congressional offices to apply what was learned on the first day. Institute participants visited their congressional delegations to discuss the need for continual support of funding for the National Institutes of Health.

See the program of activities from the 2011 ASH Advocacy Leadership Institute.

back to top
 

Photos from the 2011 ASH Advocacy Leadership Institute

The Honorable Michael Castle discusses the importance of advocacy from the congressional perspective. 

The Honorable Michael Castle discusses the importance of advocacy from the congressional perspective. (Click image to enlarge) 
Dr. Griffin Rodgers of the NIDDK responds to a question. 

Dr. Griffin Rodgers of the NIDDK responds to a question. (Click image to enlarge) 
Dr. Nicole Verdun poses a question. 

Dr. Nicole Verdun poses a question. (Click image to enlarge) 
Drs. Thomas Bradley, Jonathan Thon, Gregory Abel, and Jonathan Hoggatt pose in front of the U.S. Capitol buidling. 

Drs. Thomas Bradley, Jonathan Thon, Gregory Abel, and Jonathan Hoggatt pose in front of the U.S. Capitol buidling. (Click image to enlarge) 
2011 ASH Advocacy Leadership Institute participants gather in the Capitol Visitor Center before meeting with members of Congress. From left to right: Thomas P. Bradley, MD, Naveen Pemmaraju, MD, Gregory Abel, MD, MPH, Krishna Komanduri, MD, Jonathan Hoggatt, PhD, Lindsay Peterson, MD, Nicole Hasbrouck Verdun, MD, Jonathan N. Thon, PhD, Roy S. Silverstein, MD [Chair], Troy Lund, MD, PhD, Rachel Cook, MS, MD, Manali Patel, MD, MPH, Jeffrey S. Buzby, PhD, Ines Macias-Perez, PhD, Ann Woolfrey, MD, Sherine Elsawa, PhD, Jose F. Leis, MD, Latorya Barber, PhD, Martha Arellano, MD, Laura M. De Castro, MD, Navneet Majhail, MD, Ramon Tiu, MD. 

2011 ASH Advocacy Leadership Institute participants gather in the Capitol Visitor Center before meeting with members of Congress. (Click image to enlarge) 
ASH Advocacy Leadership Institute Class of 2011 receive certificates of participation at the 2011 ASH Annual Meeting in San Diego. From left to right: Jonathan Thon, PhD, Ramon Tiu, MD, Gregory Abel, MD, MPH, Laura De Castro, MD, Thomas Bradley, MD, Nicole Hasbrouck Verdun, MD, Jeff Buzby, PhD, Martha Arellano, MD, Jose F. Leis, MD, Rachel Cook, MS, MD, Jonathan Hoggatt, PhD, Ines Macias-Perez, PhD, Sherine Elsawa, PhD, Manali Patel, MD, MPH, Krishna Komanduri, MD, Ann Woolfrey, MD, Roy S. Silverstein, MD [Chair]. 

ASH Advocacy Leadership Institute Class of 2011 receive certificates of participation at the 2011 ASH Annual Meeting in San Diego. (Click image to enlarge) 

back to top
 

2011 ASH Advocacy Institute Participants

  • Thomas P. Bradley, MD, Hofstra-North Shore LIJ Health System, Lake Success, NY
  • Naveen Pemmaraju, MD, MD Anderson Cancer Center, Houston, TX
  • Gregory Abel, MD, MPH, Dana-Farber Cancer Institute, Boston, MA
  • Krishna Komanduri, MD, University of Miami Sylvester Cancer Center, Miami, FL
  • Jonathan Hoggatt, PhD, Harvard Medical School, Boston, MA
  • Lindsay Peterson, MD, University of Texas Health Science Center, San Antonio, TX
  • Nicole Hasbrouck Verdun, MD, Children's National Medical Center, Washington, DC
  • Jonathan Thon, Brigham and Women's Hospital, Boston, MA
  • Roy S. Silverstein, MD, Medical College of Wisconsin, Milwaukee, WI [Chair]
  • Troy Lund, MD, PhD, University of Minnesota, Minneapolis, MN
  • Rachel Cook, MS, MD, University of Wisconsin, Madison, WI
  • Manali Patel, MD, MPH, Stanford Cancer Institute, Stanford, CA
  • Jeffrey S. Buzby, PhD, Children's Hospital of Orange County, Orange, CA
  • Ines Macias-Perez, PhD, Sarah Cannon Research Institute, Nashville, TN
  • Ann Woolfrey, MD, Fred Hutchinson Cancer Research Center, Seattle, WA
  • Sherine Elsawa, PhD, Northern Illinois University, Dekalb, IL
  • Jose F. Leis, MD, Mayo Clinic Arizona, Phoenix, AZ
  • Latorya Barber, PhD, Duke University, Durham, NC
  • Martha Arellano, MD, Winship Cancer Institute of Emory University, Atlanta, GA
  • Laura M. De Castro, MD, Duke University Medical Center, Durham, NC
  • Navneet Majhail, MD, National Marrow Donor Program, Minneapolis, MN
  • Ramon Tiu, MD, Cleveland Clinic, Cleveland, OH

back to top